Brief: Chemomab Therapeutics Announces Nebokitug Phase 2 Spring Trial Results
02/12/2025 13:47
Dec 2 (Reuters) - Chemomab Therapeutics Ltd CMMB.O: CHEMOMAB THERAPEUTICS ANNOUNCES NEBOKITUG PHASE 2 SPRING TRIAL RESULTS IN PRIMARY SCLEROSING CHOLANGITIS PUBLISHED IN THE AMERICAN JOURNAL OF GASTROENTEROLOGY Source text: ID:nGNX9D7CG9 Further company coverage: CMMB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chemomab Therapeutics
See all newsBrief: Chemomab Therapeutics Announces Second Quarter 2026 Financial Results And Provides Corporate Update
Chemomab Therapeutics Ltd expected to post a loss of 15 cents a share - Earnings Preview
Israel's Chemomab Q4 net loss narrows on lower R&D spend
Brief: Chemomab Therapeutics Announces Nebokitug Phase 2 Spring Trial Results
Brief: Chemomab Therapeutics Announces Third Quarter 2025 Financial Results And Provides Corporate Update